🇺🇸 FDA
Pipeline program

Anti-Platelet Drugs

SHS-2017

Approved small_molecule active

Quick answer

Anti-Platelet Drugs for Unstable Angina is a Approved program (small_molecule) at China SXT Pharmaceuticals with 3 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Unstable Angina
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials